- Home
- FDMT vs CAF Comparison
FDMT vs CAF Comparison
Compare FDMT & CAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- CAF
- Stock Information
- Founded
- FDMT 2013
- CAF 2006
- Country
- FDMT United States
- CAF United States
- Employees
- FDMT N/A
- CAF N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- CAF Investment Managers
- Sector
- FDMT Health Care
- CAF Finance
- Exchange
- FDMT Nasdaq
- CAF Nasdaq
- Market Cap
- FDMT 192.2M
- CAF 227.6M
- IPO Year
- FDMT 2020
- CAF N/A
- Fundamental
- Price
- FDMT $4.38
- CAF $14.08
- Analyst Decision
- FDMT Buy
- CAF
- Analyst Count
- FDMT 10
- CAF 0
- Target Price
- FDMT $32.33
- CAF N/A
- AVG Volume (30 Days)
- FDMT 410.7K
- CAF 63.6K
- Earning Date
- FDMT 08-07-2025
- CAF 01-01-0001
- Dividend Yield
- FDMT N/A
- CAF 1.02%
- EPS Growth
- FDMT N/A
- CAF N/A
- EPS
- FDMT N/A
- CAF N/A
- Revenue
- FDMT $23,000.00
- CAF N/A
- Revenue This Year
- FDMT $13,048.65
- CAF N/A
- Revenue Next Year
- FDMT N/A
- CAF N/A
- P/E Ratio
- FDMT N/A
- CAF N/A
- Revenue Growth
- FDMT N/A
- CAF N/A
- 52 Week Low
- FDMT $2.24
- CAF $11.63
- 52 Week High
- FDMT $28.93
- CAF $14.38
- Technical
- Relative Strength Index (RSI)
- FDMT 56.61
- CAF 70.13
- Support Level
- FDMT $4.23
- CAF $13.61
- Resistance Level
- FDMT $4.50
- CAF $14.17
- Average True Range (ATR)
- FDMT 0.26
- CAF 0.12
- MACD
- FDMT 0.01
- CAF 0.01
- Stochastic Oscillator
- FDMT 85.37
- CAF 84.21
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CAF Morgan Stanley China A Share Fund Inc.
Morgan Stanley China A Share Fund Inc is the United States based non-diversified, closed-end management investment company. Its investment objective is to seek capital growth by investing a majority of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges. Its portfolio of investments consists of investment in different sectors such as the aerospace and defense, banks, automobiles, household durables, media, pharmaceuticals, software and other sectors.